The genus *Citrobacter*, a group of facultative, anaerobic and Gram-negative bacilli, belongs to the family Enterobacteriaceae. *Citrobacter* strains are often isolated from water, soil, food and intestinal tracts of animals and humans \[[@B1]\], and can cause bacteremia, meningitis, sepsis, peritonitis, urinary tract infections, respiratory tract infections and postoperative infections, especially in infants, children under the age of 6 years and immunocompromised individuals \[[@B2]\]. In particular, invasive *Citrobacter* infections are associated with high mortality rate, with 33--48% of patients succumbing to *Citrobacter* bacteremia \[[@B6]\]. Owing to high isolation rate, and severe infection and high mortality in the clinic, *Citrobacter* is considered an important opportunistic pathogen \[[@B3]\].

The *Citrobacter* genus is divided into 11 different genomospecies \[[@B9]\]. *C. freundii* and *C. koseri* constitute the most important pathogenic species and have the highest isolation rate in the clinic \[[@B4],[@B10],[@B11]\]. *Citrobacter* is most closely related to *Escherichia coli* and *Salmonella* \[[@B12]\], albeit with higher level of diversity. For example, the branch lengths separating certain pairs of *Citrobacter* species are almost as long as those separating *E. coli* and *Salmonella* \[[@B13]\].

Several more recently developed molecular typing methods, such as pulsed-field gel electrophoresis, multilocus sequence typing and restriction fragment length polymorphism, have been used to detect and genotype the *Citrobacter* clinical isolates \[[@B8],[@B14]\]. However, the serotyping scheme based on variations in O-antigens is still the 'gold standard' for Gram-negative pathogen detection and identification in clinical specimens and environmental samples \[[@B17]\].

West and Edwards first established an antigenic scheme comprising 32 O-serogroups for *Citrobacter* in 1954 \[[@B18],[@B19]\], which was extended to 43 O-serogroups in 1966 by Sedlak and Slajsova \[[@B12],[@B20]\]. Although this serotyping scheme has been widely accepted and applied for *Citrobacter* \[[@B19],[@B21],[@B22]\], it has not been updated since 1966. Furthermore, considering that O-antisera of *Citrobacter* are currently not commercially available, the majority of laboratories are unable to perform conventional antigenic typing. In addition, cross-reactions between *Citrobacter* and other genera of Enterobacteriaceae, such as *Escherichia*, *Klebsiella*, *Hafnia* and *Salmonella*, hinder accurate identification of *Citrobacter* \[[@B19]\]. Molecular methods are more specific and sensitive than traditional methods. Among these, microarrays allow large-scale detection of multiple targets because of their throughput power. In recent years, the Luminex-based suspension array has become an attractive approach for pathogenic detection of both protein and nucleic acids, and has been approved by the US FDA for clinical diagnosis in various applications \[[@B23],[@B24]\].

The diversity of the O-antigen arises mainly from genetic variations in the O-antigen biosynthesis gene clusters (O-AGCs), which provides the basis for molecular O-serotyping \[[@B25]\]. Most genes in an O-AGC are involved in one of the following three functions: nucleotide sugar synthesis, sugar transfer and O unit processing \[[@B26]\]. In particular, the O-antigen processing genes *wzy*, *wzx*, *wzm* and *wzt* are highly serotype determinative, and have hence been widely used as target genes in molecular serotyping of many Gram-negative bacteria \[[@B27]\]. Notably, the consistency between O-AGC genetic variation-based molecular serotyping and the conventional serotyping scheme has been demonstrated in several genera \[[@B28],[@B30]\].

However, studies on *Citrobacter* O-antigens have mainly focused on the structures \[[@B22],[@B34]\] instead of diversities of O-AGCs. In the present study, we determined the location of O-AGC in *Citrobacter* genome and its function by deletion and complementation testing. We subsequently obtained 18 O-AGCs of *Citrobacter* by whole-genome sequencing. We then developed a molecular O-serotyping system using a microsphere-based suspension array (MSA) platform based on the specific genes of O-AGCs. In addition, we also established a valid, genome-based tool for *in silico* serotyping of *Citrobacter*. All 98 *Citrobacter* genome sequences available in GenBank (National Institutes of Health \[NIH\], MD, USA) were subjected to the genome-based serotyping tool, and 90 were classified into 33 novel O-AGC groups. We provided alternatives in this study to perform faster and easier O-serotyping of *Citrobacter* using both experimental and bioinformatic approaches. Finally, we demonstrated the potential of this method for epidemiological surveillance and clinical identification of *Citrobacter*.

Materials & methods {#S0001}
===================

Bacterial strains & genomic DNA extraction {#S0002}
------------------------------------------

In total, 18 *Citrobacter* strains were obtained from the Polish Collection of Microorganisms (PCM) at the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (Wroclaw, Poland). The details of the bacterial strains used in this study are listed in [Table 1](#T1){ref-type="table"}. *Citrobacter* strains were grown in Luria broth on an orbital shaker at 180 rpm and 37°C overnight. The genomic DNAs were extracted using a bacteria extraction kit (CWBIO Co. Ltd, Beijing, China) and stored at -20°C.

###### ***Citrobacter* strains sequenced in this study.**

  **Lab collection NO.**   **Species**      **Serovar**   **Structure reference**   **Gene cluster accession number**
  ------------------------ ---------------- ------------- ------------------------- -----------------------------------
  G3336                    *C. youngae*     O3            19                        MH325885
                                                                                    
  G3337                    *C. youngae*     O4            19                        MH325886
                                                                                    
  G3340                    *C. braakii*     O5            19                        MH325887
                                                                                    
  G3341                    *C. braakii*     O6            22                        MH325888
                                                                                    
  G3344                    *C. braakii*     O7            19                        MH325889
                                                                                    
  G3518                    *C. braakii*     O8            19                        MH325890
                                                                                    
  G3533                    *C. gillenii*    O9            19                        MH325891
                                                                                    
  G3535                    *C. gillenii*    O12           19                        MH325892
                                                                                    
  G3537                    *C. werkmanii*   O14           39                        MH325893
                                                                                    
  G3541                    *C. youngae*     O16           19                        MH325894
                                                                                    
  G3515                    *C. freundii*    O22           38                        MH325895
                                                                                    
  G3516                    *C. freundii*    O23           19                        MH325896
                                                                                    
  G3521                    *C. werkmanii*   O24           19                        MH325897
                                                                                    
  G3522                    *C. werkmanii*   O26           19                        MH325898
                                                                                    
  G3919                    *C. braakii*     O30           19                        MH325899
                                                                                    
  G3543                    *C. youngae*     O32           19                        MH325900
                                                                                    
  G3538                    *C. werkmanii*   O38           19                        MH325902
                                                                                    
  G3915                    *C. freundii*    O41           19                        MH325903

Draft genome sequencing & analysis {#S0003}
----------------------------------

Whole genomes of the 18 *Citrobacter* strains were sequenced using Solexa pair-end sequencing technology \[[@B40]\]. The Solexa Genome Analyzer IIx (Illumina, Little Chesterford, Essex) was used to a depth of 90- to 100-fold coverage. The Illumina data were *de novo* assembled using the Velvet Optimizer v2.2. Polymerase chain reaction (PCR) was used to close gaps within the major genes in O-antigen biosynthesis gene clusters, and the PCR products were sequenced using traditional Sanger sequencing. In total, 98 genome sequences of *Citrobacter* were downloaded from the GenBank database (listed in [Supplementary Table 1](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s2.xlsx)). Detailed analyses of genes in each O-AGC were performed using BLAST search (NIH).

Construction of the *wzm* deletion mutant strain & complementary strain of *C. werkmanii* O26 {#S0004}
---------------------------------------------------------------------------------------------

*wzm* of the *C. werkmanii* O26 (G3522) strain was deleted as described previously \[[@B41]\], with some modifications. A common plasmid pKD46 (Novagen, Trento, Italy) was used instead of pKD46-Gm as G3522 is not resistant to ampicillin. The concentration of L-arabinose was increased to 4 mM to induce recombination. *wzm* was finally replaced by a kanamycin resistance cassette from plasmid pKD4. The O26 △*wzm* strain was termed H2659. A complementary strain with full ABC transporter function was also constructed using the plasmid pTRC99a harboring the original *wzm* from strain G3522. The recombinant plasmid was transferred into H2659 to complement for the loss of *wzm*. The complementary strain was termed H2660. Strains, plasmids and primers used for generating and identifying H2659 and H2660 are listed in [Supplementary Table 2](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s3.docx).

Extraction & silver staining of lipopolysaccharide {#S0005}
--------------------------------------------------

Lipopolysaccharide (LPS) was extracted using hot aqueous-phenol extraction as described previously \[[@B42]\]. In the present study, we pelleted the bacteria from 20 ml cultured Luria broth medium and quadrupled all the reagent dosages. The extracted LPSs of G3522, H2659 and H2660 were separated by 13% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS--PAGE). Silver staining was performed using the Fast Silver Stain kit (no. P0017S, Beyotime, Shanghai, China).

Primer & probe design {#S0006}
---------------------

Primers and probes were designed based on the sequences of *wzx*, *wzy*, *wzm* and *wzt*. As O4 does not contain any of these genes in its O-AGC, the gene encoding glycosyl transferase (GT) was selected as the target. For O7 and O26, another set of primers and probes were designed based on *gtrC*. Biotin was used to label to the 5′-end of reverse primers (Invitrogen Co. Ltd, Beijing, China). Probes were synthesized with an amino C-12 module at the 5′-end (AUGCT, Beijing, China). Primers and probes used in this study are listed in [Table 2](#T2){ref-type="table"}.

###### **Primers and probes used in *Citrobacter* molecular typing.**

  **OAgc form**   **Target gene**   **Forward/reverse primers (5′-3′)**   **Product size (bp)**   **Probes**
  --------------- ----------------- ------------------------------------- ----------------------- -----------------------------------------
  O3              *wzm*             wl-72175:TTTTTCGCGATGTTGGG            212                     OA-5600:TCCTATGGCTAGCGTGATTGAG
                                                                                                  
                                    wl-72176:ACCAAGACTAAGTGGGTAGATTAA                              
                                                                                                  
  O7              *wzm*             wl-72175:TTTTTCGCGATGTTGGG            212                     OA-5600:TCCTATGGCTAGCGTGATTGAG
                                                                                                  
                                    wl-72176:ACCAAGACTAAGTGGGTAGATTAA                              
                                                                                                  
  O7              *gtrC*            wln-12418:TATCTTTTAGCGATGGCACTT       236                     OAn-171:CCGCTGATGGGTATGGTTTC
                                                                                                  
                                    wln-12419:GAGTATGGTGGGTAATAAGGGT                               
                                                                                                  
  O4              *GT*              wl-72149:CCTGGTAGCCTCACGATAGA         219                     OA-6027:GAGTTACCTGGTCATGTGGATAATG
                                                                                                  
                                    wl-72150:AACTACGGTCTCCCGACAC                                   
                                                                                                  
  O5              *wzm*             wl-72155:ATCCTGGCATCTTTGGACT          336                     OA-6031:GAAGGGTGTGTAACTTTCATATCGT
                                                                                                  
                                    wl-72156:ACTATATTATGGCAAAGCATCATA                              
                                                                                                  
  O6              *wzm*             wl-72157:CATGGCGGCGGTACA              261                     OA-6034:GGTAGTGGCATACGCAGTCTTTT
                                                                                                  
                                    wl-72158:CAGGATCGTTAGATGCGG                                    
                                                                                                  
  O8              *wzm*             wl-72187:TTCTGTCGGGCTGGGTAT           258                     OA-5606:TTGATGCGCTACCGGAAAA
                                                                                                  
                                    wl-72188:ATTCCACCGGATATTAGAACA                                 
                                                                                                  
  O9              *wzm*             wl-72193:TTGGCCTGTGCTGGATC            273                     OA-6037:TGTGTTGATTGACTATAACCCTGTATATC
                                                                                                  
                                    wl-72194:TAGGCCATTCGCCTTGTA                                    
                                                                                                  
  O12             *wzx*             wl-73677:CTGTATCTCTCCAAAGCCACTC       252                     OA-6266:TACCGCAAGTAAGGTTAGTTTTTTATAG
                                                                                                  
                                    wl-73678:AATTTCGGCGACTCTATATCAT                                
                                                                                                  
  O14             *GT*              wl-72195:GGCTGCTGTAGCGAGGA            249                     OA-5610:CGGCAACTGGACGGTTTATT
                                                                                                  
                                    wl-72196:CAACCTATATCACAACCTCTAAGC                              
                                                                                                  
  O16             *wzy*             wl-72165:AATCACGATGTGGAAGCTG          308                     OA-5595:CTAATCACGTTACCCCTTATTGGT
                                                                                                  
                                    wl-72166:CCAAATCTCCCGAAACTAAATA                                
                                                                                                  
  O22             *wzy*             wln-743:GTTTCTCGCAAGGTGGAGTAG         267                     OAn-35:CAATTACCCTTTCTAGTTAAGGTC
                                                                                                  
                                    wln-744:CAAAAGCATAAGCAGAGTAAACAC                               
                                                                                                  
  O23             *wzy*             wln-759:TTGTGGTTGGGATTTGTCAG          471                     OAn38:ATTTATCAAGGTTTCAAAAGTCC
                                                                                                  
                                    wln-760:GTAATCCTGCTAAGGTTGAAGATAG                              
                                                                                                  
  O24             *wzx*             wl-72159: GGTCTGCTTGTAGGAGTATGG       299                     OA-6043: TATGTTTAATCGTGGCAGTGGG
                                                                                                  
                                    wl-72160: AATACTAGTCCACCACCAGCC                                
                                                                                                  
  O26             *wzm*             wl-72179: GCAAGTAGATATCAAGGTTCAGTT    328                     OA-5602: TTGGTCTGCAGATAGTACAGGAAGT
                                                                                                  
                                    wl-72180: CCCAAACGACAAAGCTAATT                                 
                                                                                                  
  O26             *gtrC*            wln-12420: ATTAGGCGTGAGCAGTAGAGG      444                     OAn-172: TGTAGATCCTCGCGGCCTAT
                                                                                                  
                                    wln-12420: GGCTTCTCGAAATCATTTTGTA                              
                                                                                                  
  O30             *wzm*             wl-72179: GCAAGTAGATATCAAGGTTCAGTT    328                     OA-5602: TTGGTCTGCAGATAGTACAGGAAGT
                                                                                                  
                                    wl-72180: CCCAAACGACAAAGCTAATT                                 
                                                                                                  
  O32             *wzm*             wl-72167: GTGTAGTATCGTCATCGTTGTTAG    294                     OA-5596: CTATGGTATATCACCTACAGTAGAGTGGTT
                                                                                                  
                                    wl-72168: AGGTTATAAAGCGTTCTAAATCC                              
                                                                                                  
  O38             *wzy*             wl-72161: TTTGACCCGAGGGGC             361                     OA-5593: CAGACATCACGTGGGTCTACG
                                                                                                  
                                    wl-72162: TCCAGTTTCTAGTGCCATCC                                 
                                                                                                  
  O41             *wzy*             wl-72185: ATACTGGAGCAGCTAAGACAATT     341                     OA-6040: TGCCGTTTTTACTAAGATTCAAGTT
                                                                                                  
                                    wl-72186: ATTATTGAAGGGCCAACATG                                 

Multiplex PCR {#S0007}
-------------

Multiplex PCR was performed in a 50 μl reaction mixture containing 100 ng DNA template, 1× Goldstar PCR buffer, 10 μM of each deoxynucleotide triphosphate (dNTP), 0.5 μM of each forward primer, 2 μM of each reverse primer and 2.5 units of Goldstar Taq polymerase (CWBIO Co. Ltd, Beijing, China). Initial denaturation of DNA was performed for 10 min at 95°C, followed by 35 cycles of 95°C for 30 s, 58°C for 30 s, 72°C for 30 s and a final extension at 72°C for 10 min. PCR products were stored at 4°C for use in the subsequent experiments.

Probe-microsphere coupling {#S0008}
--------------------------

Unique colored fluorescent microspheres can be detected in multiplex PCR reactions using the Luminex xMAP technology. The microspheres (Bio-Rad Laboratories, CA, USA) were conjugated to the 5¢-end amino C-12 modification according to the manufacturer\'s instructions (Luminex Corporation, TX, USA). Briefly, 80 μl microspheres was suspended in 10 μl 0.1 M 2-(N-morpholino) ethanesulfonic acid, pH 4.5 (MES); subsequently, 2 μl probes and 6 μl fresh 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (10 mg/ml) were added; After incubating for 1 h, the probe-microsphere conjugated products were washed in 1 ml 0.02% Tween-20 (Sigma-Aldrich, MO, USA) and 1 ml 0.1% SDS (Sigma-Aldrich). Finally, the coupled microspheres were resuspended in 25 μl Tris-EDTA buffer, pH 8.0 (Sigma-Aldrich) and stored at 4°C in the dark. Notably, the whole coupling process was performed in dark to avoid fluorescence quenching.

Hybridization & suspension array performance {#S0009}
--------------------------------------------

A 2 μl sample of each 18 probe-microsphere conjugated product was mixed and diluted with 1.5× tetramethylammonium chloride (TMAC) solution (Sigma-Aldrich) that contained 4.5 M TMAC, 0.15% Sarkosyl, 75 mM Tris-HCl (pH 8.0) and 6 mM EDTA (pH 8.0). Further 33 μl bead mixture was added to 17 μl of each PCR product. The 50 μl hybridization reactions were denatured at 95°C for 5 min, hybridized at 60°C for 15 min, transferred to a multiscreen-HV filter plate (Millipore, MA, USA) and the supernatants removed after centrifuging at 1000 rpm for 1 min. The hybridized products were next washed twice with 70 μl 1× TMAC and resuspended in 80 μl of 4 μg/ml streptavidin labeled with R-phycoerythrin (SAPE; Invitrogen), which was diluted in 1.0× TMAC. Finally, the hybridized products were analyzed using a Bio-Plex 100 suspension array system (Bio-Rad Laboratories). The fluorescent signals were captured using a digital signal processor and Bio-Plex Manager 4.1 software. Background controls were set up using all ingredients except the template DNA. The background was subtracted from each sample signal, and the positive signals of specific probes were considered to possess at least triple the fluorescence intensity resulting from nonspecific binding.

Sensitivity detection {#S0010}
---------------------

To determine the minimum detection level of purified DNA, tenfold serial dilutions of genomic *Citrobacter* DNA (100 to 10^-6^ ng) were prepared and used as templates for MSA detection. To determine the sensitivity of our MSA system for pure cultures, *Citrobacter* cultures were tenfold serially diluted to 10^8^ to 10^0^ colony forming units (CFU)/ml and used as templates for MSA detection. The multiplex PCR and suspension array detection procedures were identical to that described above.

Construction of *in silico* serotyping program {#S0011}
----------------------------------------------

A Python script was constructed for prediction of *Citrobacter* serotypes with genome data (available in [Supplementary Tool](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s1.pdf)). The database was constructed based on the O-serotype specific genes *wzx*, *wzy*, *wzm*, *wzt*, *gtrC* and GT, for *in silico* O typing. All specific genes of *Citrobacter* strains assigned to different serotypes were stored in the database. Genome assemblies were subjected to a BLASTn search against the O-serotype specific gene database with an identity cutoff \>98% and a minimum length of 95%. The script outputs the best-matching genes from the BLAST analysis, as well as percentage identity between the gene detected in the query genome and the O-serotype specific gene. In addition, the script outputs the predicted O serotypes, based on the best-matching genes.

Accession numbers {#S0012}
-----------------

All 18 O-AGC sequences of *Citrobacter* are available from the GenBank database (accession numbers from MH325885 to MH325900, and from MH325902 to MH325903).

Results & discussion {#S0013}
====================

Location & detailed analyses of O-AGC in *Citrobacter* O26 strain {#S0014}
-----------------------------------------------------------------

Whole-genome-sequencing of *C. werkmanii* O26 (strain G3522) predicted a putative O-AGC, consisting of nucleotide sugar biosynthesis genes, three sugar transfer genes (GTs) and the O unit processing genes *wzm* and *wzt* ([Figure 1](#F0001){ref-type="fig"}). The putative O-AGC is located between two housekeeping genes *galF* and *gnd* in the genome ([Figure 1](#F0001){ref-type="fig"}). We subsequently analyzed the putative O-AGC in detail to investigate whether it correlated to the O-antigen structure. The reported O-antigen structure showed that the main chain of the O26 antigen unit consists of a 2-acetamido-2-deoxy-D-mannose (D-ManNAc) residue and a D-glucose (D-Glc) residue, with a D-Glc residue on the side chain. *orf8* in O26-AGC shares 77% identity with MnaA of *Aeromonas hydrophila* (accession number WP_101613945.1), which converts UDP-GlcNAc to UDP-ManNAc \[[@B43]\]. The biosynthesis pathway is shown in [Supplementary Figure 1](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s1.pdf). We therefore predicted that *orf8* is responsible for the biosynthesis of UDP-ManNAc in *Citrobacter* O26. In turn, the D-Glc residue is considered to comprise a common sugar that is involved in basic cell metabolism. As genes for D-Glc biosynthesis are not always located in the O-AGC but may be found elsewhere in the genome in other genera \[[@B44]\], we considered that the same condition may occur in *Citrobacter*.

![**The O-antigen biosynthesis gene clusters of 18 *Citrobacter* strains.**\
The arrows represent transcription direction and location of putative genes in O-antigen gene clusters. Different colors represent different kinds of gene functions. The proposed functions of glycosyltransferases are shown.](fmb-13-1511-g1){#F0001}

Furthermore, early reports indicated that a *gtr* operon found in phages is responsible for the glucosylation of the basic O-antigen unit on the side chain \[[@B45]\]. *gtrABs* are highly conserved, whereas the third gene, *gtrC*, is always unique to different serotypes \[[@B46]\]. GtrA and GtrB add the glucose to a carrier lipid and flip it to the periplasm, whereas GtrC performs the modification by adding a glucosyl group to the O-antigen units \[[@B47]\]. A whole genome search of O26 revealed, two conserved genes, *gtrA* and *gtrB*, in the bacteriophage as expected. In addition, as the gene adjacent to *gtrAB* shares 41% similarity with *gtrC* in *Edwardsiella tarda* (accession number PVD63346.1), we annotated it as *gtrC* and proposed that it was responsible for the glucosylation of the O26 antigen unit on the side chain. Characteristics of each gene in the O-AGC are summarized in [Supplementary Table 3](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s4.xlsx). These analyses demonstrated that O26-AGC shows good correlation with the O26 antigen structure.

Function identification of the O-AGC in *Citrobacter* by deletion & complementation testing {#S0015}
-------------------------------------------------------------------------------------------

A deletion and complementation experiment was performed on *C. werkmanii* O26 to further confirm the function of the putative O-AGC. Specifically, we replaced *wzm* with a gene encoding chloramphenicol acetyltransferase, and the mutation was complemented by the plasmid pTrc99a containing the O26 *wzm* gene. The SDS-PAGE profiles of LPS showed that compared with the wild-type G3522, the △*wzm* strain (H2659) was unable to biosynthesize O-antigen, whereas the complemented strain H2660 showed restored function ([Figure 2](#F0002){ref-type="fig"}). These results confirmed that the putative O26-AGC is responsible for the biosynthesis of the O-antigen.

![**Detecting lipopolysaccharide from the △*wzm* strain of *C. werkmanii* O26.**\
Lipopolysaccharide was extracted using the hot aqueous-phenol method. The extracts were electrophoresed on 13% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel and stained by silver staining. Lane 1: G3522 (*C. werkmanii* O26 wild type strain); lane 2: H2659 (O26 with *wzm* deletion); lane 3: H2660 (O26 with plasmid pTRC99a harboring O26 *wzm*).](fmb-13-1511-g2){#F0002}

General features of putative O-AGCs in 18 *Citrobacter* strains {#S0016}
---------------------------------------------------------------

For establishing a molecular serotyping system using the MSA platform, we sequenced 17 other *Citrobacter* strains ([Table 1](#T1){ref-type="table"}), the O-antigen structures of which have been reported, to obtain the O-AGCs. Each of the 17 O-AGCs is located between *galF* and *gnd* ([Figure 1](#F0001){ref-type="fig"}). Including O26, the sizes of the 18 O-AGCs of *Citrobacter* range from 2415 to 20,559 bp, with the average %GC content being approximately 37%, which is significantly lower than that of the entire *Citrobacter* genome (50%), indicating that O-AGCs may have been derived from another genus and consistently show the typical features of O-AGCs in Enterobacteriaceae. Generally, the O-AGCs contain genes associated with nucleotide sugar synthesis, sugar transfer and O unit processing in each O-AGC of the 17 strains, with the exception of O4 ([Supplementary Results](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s1.pdf)). We reasoned that biosynthesis of the O4 antigen may differ from those of other *Citrobacter* strains. Seven serotypes, namely, O12, O16, O22, O23, O24, O38 and O41, contain *wzx* and *wzy* in their respective O-AGC, and process O-antigen in a Wzx/Wzy-dependent pathway. The other ten serotypes containing *wzm* and *wzt* process O-antigen in an ABC transporter-dependent pathway. Detailed analysis of each of the 17 O-AGCs of *Citrobacter* showed that they exhibited good correlation with their O-antigen structures ([Supplementary Results](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s1.pdf)).

Molecular serotyping system on the MSA platform {#S0017}
-----------------------------------------------

As the O-antigen processing genes *wzy*, *wzx*, *wzm* and *wzt* have been successfully utilized for molecular serotyping of many Gram-negative bacteria \[[@B27]\], these were selected as specific targets for *Citrobacter* serotyping in the present study. *wzm* in O3, O5, O6, O7, O8, O9, O14, O26, O30 and O32, *wzx* in O12 and *wzy* in O16, O22, O23, O24, O38 and O41 were selected. Furthermore, compared with genes involved in nucleotide sugar precursor synthesis, genes encoding glycosyl transferase are heterogeneous among serotypes owing to the wide range of possible monosaccharide linkages (although showing less serotype determination than the O-antigen processing genes) \[[@B29],[@B48]\]. Since no O-antigen processing gene was present in O4-AGC, a GT (*orf2*) was selected for this serotype ([Table 2](#T2){ref-type="table"}). These selected genes were subjected to bioinformatic analysis, which revealed no sequence similarity after pairwise alignment of any two sequences, except for two pairs of strains (O3/O7 and O26/O30). As detailed analyses of the 18 O-AGCs indicated that O26 and O30 O-AGCs shared high identity (99%) ([Supplementary Figure 2](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s1.pdf)), a single set of O-AGC-specific-gene-based primers and probe was unable to distinguish these homologous strains. However, although O26 and O30 share the same main chain of the O-antigen unit, O26 carries a glucosylation on the side chain, encoded by the *gtr* operon. Therefore, to further distinguish O26 from O30, we designed another set of primers and probe based on the serotype-specific gene *gtrC*. Similarly, between O3 and O7, the O7-antigen is glucosylated on the side chain, whereas the main chain is identical to the linear O-antigen of O3. Hence, we also designed a set of primers and probe based on *gtrC* of O7.

Strains representing all 18 serotypes, together with ten other *Citrobacter* strains of ten diverse serotypes, were used to test the specificity of these specific gene-based primers and probes on the MSA platform. The MSA results showed that each O-AGC-specific probe detected the homologous strains correctly and no signals corresponding to heterologous strains were observed, whereas both *wzm*-based and *gtrC*-based signals were detected in O7 and O26 ([Figure 3](#F0003){ref-type="fig"}). To test the reproducibility of the molecular serotyping system on the MSA platform, three parallel tests were performed independently and the error bars were shown in [Figure 3](#F0003){ref-type="fig"}.

![**Fluorescence signals of the O-serotype system on the microsphere-based suspension array platform.**\
Each cube represents a fluorescence signal from mixed microspheres that had combined with a template PCR amplicon irrespective of whether it represented the correct target. The X-axis shows the probes, whereas the Y-axis shows the different O-serotype strains. The Z-axis shows the fluorescence signal values. The higher the cube, the more the combinations between microspheres and amplicons.\
MFI: Median fluorescence intensity.](fmb-13-1511-g3){#F0003}

The MSA experiments revealed that each probe was specific to its homologous DNA, and the specific fluorescence signal was at least threefold more intense than the nonspecific signals ([Figure 3](#F0003){ref-type="fig"}). No cross-reaction was observed in the test. Several bacterial strains, namely, *E. coli* (n = 4), *Shigella* spp. (n = 4), *Salmonella* spp. (n = 3), *Klebsiella pneumoniae* (n = 3), *Vibrio cholerae* (n = 2) and *Legionella* spp. (n = 2), which were used to determine the specificity of primers and probes yielded negative results (data not shown). To assess the availability of our MSA technique, a double-blind test was conducted using 87 clinical isolates from Shanghai Municipal Center for Disease Control. Among them, two isolates were designated as O5, three as O8, seven as O22 and four as O41, with six isolates each representing individual serotype and 65 being nontypeable. All strains assigned certain serotypes were confirmed to be correct using ABI 3730 sequencing of each single PCR product. In addition, a sensitivity test of molecular serotyping system on the MSA platform was performed using genomic DNAs or pure cultures from O5, O8, O22 and O41, as they appeared at a relatively high proportion. Our test demonstrated that positive signals could be generated for templates containing 10^-2^ ng of genomic DNA or 10^3^ CFU of pure culture.

O-serotyping *in silico* using genome data of *Citrobacter* {#S0018}
-----------------------------------------------------------

A program was next designed to develop an O-serotyping scheme *in silico* for *Citrobacter* using only the genome data. The database covered the 18 studied O-serotypes of *Citrobacter*, which were represented by the genes used in the serotyping system on the MSA platform as listed in [Table 2](#T2){ref-type="table"}. Most serotypes were represented only by a single *wzy*, *wzx* or *wzm*, whereas O7 and O26 were represented by both *wzm* and *gtrC*. To evaluate and extend the *in silico* serotyping program, 98 publicly available *Citrobacter* genomes in GenBank were subjected to the program. Among these, eight *Citrobacter* genomes were assigned to the 18 O serotypes contained in the database, with a threshold of 98% identity and a minimum length of 95%. We then extracted the O-AGCs from these eight genomes and conducted further analyses. The composition and arrangement of genes in each of the eight O-AGCs were identical to those in their assigned serotypes, which validated the credibility of the *in silico* serotyping method ([Supplementary Figure 3](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s1.pdf)).

We also extracted all the O-AGCs from the 90 unallocated *Citrobacter* genomes for further analysis. According to the composition and arrangement of genes, we classified the 90 O-AGCs into 33 novel O-AGC groups ([Supplementary Figure 4](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s1.pdf)), a portion of which may overlap with the reported 43 known serotypes of *Citrobacter*. This classification indicated the existence of hitherto-unrecognized genetic O variation in *Citrobacter*. Each of the O-AGC groups, which were temporarily termed O-AGC temp 1 to O-AGC temp 33, was represented by one of the *wzy*, *wzx*, *wzm* and *wzt* genes ([Supplementary Table 4](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s5.xlsx)) and were added in the *in silico* serotyping program. Once their assignment to the exact O serotypes is established, the temporary name will be replaced with the widely recognized O-serotypes of *Citrobacter*. Furthermore, 25 *Citrobacter* genomes in GenBank were derived from a single strain and with identical O-AGCs \[[@B49]\]; these have been represented as RU2 in [Supplementary Figure 4](/doi/suppl/10.2217/fmb-2018-0187/suppl_file/fmb-13-1511-s1.pdf).

The O-serotyping system using the MSA platform based on *Citrobacter* O-AGCs was shown to correlate well with the conventional antigenic method. In addition, the program developed in this study offered another superior *in silico* serotyping method using genome data, which enabled the rapid and high-throughput serotyping of *Citrobacter*. Although we only targeted 18 serotypes of *Citrobacter* strains in this study, both the experimental and bioinformatic serotyping systems have the ability to be updated in real-time as novel specific primers, probes and genes can be easily added into our serotyping systems. In the future, we plan to sequence other *Citrobacter* strains belonging to different serotypes, the O-antigen structures of which have been previously reported, to determine whether their O-AGCs are also consistent with their O-antigen structures. Sequence alignments will be subsequently conducted to ascertain whether the serotype-specific genes of these novel *Citrobacter* O-AGCs are already present in the database of our *in silico* serotyping program, inclusion of any nonrepresented genes in our database, and addition of specific-gene-based primers and probes in the O-serotyping system of the MSA platform. Furthermore, for *Citrobacter* strains with glucosylation on the O-antigen side chain, *gtrC* can be considered as another serotype-specific gene and the relevant gene sequences, primers and probes will also be included in the serotyping tools to facilitate accurate identification. Overall, the two serotyping tools developed in this study represent potentially powerful approaches for detecting and identifying *Citrobacter* in environmental and clinical samples, as well as for epidemiological surveillance and tracing.

Conclusion {#S0019}
==========

In this study, we first located the O-AGCs of *Citrobacter* by genomic and biochemical analyses and further characterized the O-AGCs of 18 serotypes, thereby providing the basis for the evolution of O-antigens of this pathogenic bacterium. Next, a highly sensitive and specific molecular serotyping assay based on the MSA platform was developed and an *in silico* serotyping method was presented. These tools show considerable potential for the clinical diagnosis and epidemiological surveillance of the genus *Citrobacter*.

Future perspective {#S0020}
==================

The serotyping technique has been used as a standard tool for bacterial detection and epidemiological studies. With the emergence and development of whole genome sequencing technologies and automated data analysis pipelines, several genomics-based methods are being used for routine serotyping and surveillance of pathogens, showing potential advantages in public health microbiology. The O-AGCs of the remaining serotypes of *Citrobacter* have to be identified to promote its clinical application.

###### Summary points

-   The widespread and fatal infections of *Citrobacter* highlight the necessity of establishing accurate and rapid molecular typing systems for effective surveillance and clinical detection of this bacterium. However, the lack of commercial *Citrobacter* O-antisera has limited the application of conventional serotyping. In the present study, we developed rapid and simple experimental and *in silico* serotyping systems for *Citrobacter*.

-   Here, we located the O-antigen biosynthesis gene cluster (O-AGC) in *Citrobacter* genome by genomic and molecular analyses, and the biological function was verified experimentally for the first time.

-   Subsequently, we sequenced the whole genome of 18 *Citrobacter* strains and obtained the O-AGCs. Based on the specific genes in these O-AGCs, we developed a sensitive molecular serotyping system using a microsphere-based suspension array platform.

-   Additionally, we established an *in silico* serotyping method for *Citrobacter* based solely on the whole genome sequencing data. All 98 available *Citrobacter* genomes in GenBank were used to test the reliability of this *in silico* serotyping method, and a previously unrecognized level of diversity was revealed.

-   Notably, the two tools developed in this study enabled us to perform *Citrobacter* O-serotyping using both experimental and bioinformatic approaches. The system can be conveniently updated in real-time, allowing addition of new O-AGCs identified in different laboratories, which will supplement the two serotyping tools.
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